Certified Registered Nurse Infusion (CRNI) Practice Exam

Cytovene, also known as ganciclovir, is an antiviral medication specifically indicated for the treatment of cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as those with HIV/AIDS or organ transplant recipients. CMV is a common virus that can cause significant morbidity and mortality in these populations, leading to conditions like retinitis, pneumonia, and gastrointestinal disease.

Ganciclovir works by inhibiting viral DNA synthesis, effectively slowing the replication of CMV and thereby helping to control the infection. Its use is particularly critical in those who are at high risk of developing severe disease due to their weakened immune systems.

In contrast, other conditions listed, such as severe allergic reactions, chronic lung disease, and fungal infections, do not respond to ganciclovir, as they require different therapeutic agents tailored to their specific pathologies. This specificity highlights the importance of correct drug selection based on the type of infection being treated, demonstrating the targeted nature of antiviral therapies like Cytovene.